Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by Interpolation1on Oct 18, 2016 8:28am
100 Views
Post# 25354770

RE:RE:THC BIOMED RECEIVES LICENSE AMENDMENT

RE:RE:THC BIOMED RECEIVES LICENSE AMENDMENT
THC BioMed Receives License Amendment

VANCOUVER, BC--(Marketwired - October 18, 2016) - THC BioMed Ltd. (CSE: THC)(OTC PINK: THCBF)(FRANKFURT: TFHC)("THC" or the "Company") is pleased to report that it has had its license amended by Health Canada and will begin to initiate its business plan by inter-trading between licensed producers to strengthen its products and service.

THC is currently working on good production practices surrounding the supply of starting material to registered patients, once regulatory requirements have been met and our E-Commerce Platform has been initiated.

THC intends to offer its 29 strains of dried Marihuana as well as Cannabis oil and Cannabis Resin, to patients registered under the ACMPR.

Management continues to work diligently to increase shareholder value while practicing fiscal discipline.

THC's vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC. Forward-looking information is based on certain key expectations and assumptions made by the management of THC. Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

THC Biomed Intl Ltd.
John Miller
President and CEO
T. 604 682-1643
E. info@thcbiomed.com




Remia9 wrote: Yes. But more exciting news on the way this week.

Jeffwee wrote: The news we've all been waiting for is finally here.
https://thecse.com/sites/default/files/THC_recieves_licence_amendment_.pdf





Bullboard Posts